Tufts University has opened a 15,000 square-foot biotech incubator managed by BioLabs with enough room for 100 scientists and entrepreneurs.

Celsius Therapeutics, which has launched with series A capital, has become the latest Third Rock-launched company to be backed by GV.

Bharat Inclusion Initiative has already raised $12.5m to back projects in sectors such as financial inclusion, livelihood, education and health.

6 Dimensions Capital led a round for the miniprotein drug developer that included Nan Fung, GV and WuXi AppTec Corporate Ventures.

Imprimis spun out Surface in 2017 to develop ocular surface treatments but its stake will be cut to 30% following Flying L Partners' investment.

Kadmon remains the largest shareholder of gene therapy developer MeiraGTx, which has filed to raise up to $86.3m on the Nasdaq Global Market.

Acousia has raised $11.8m from backers including Boehringer Ingelheim Venture Fund to advance therapies for inner-ear impairments into the clinic.